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ABSTRACT 
 Sepsis and its manifestation as a shock state in “septic shock” have long caused 
medical issues and death worldwide. The disease requires quick identification, diagnosis, 
and intervention with very high mortality rates prevalent otherwise. Historically this has 
been due to limited awareness of the disease and misclassification of its prevalence, 
severity, and incidence. Luckily in the past decade there has been increased interest and 
therefore resources devoted towards improving care and further understanding a disease 
that is one of the leading causes of mortality in hospitals worldwide. Over the past 
handful of years novel interventions and diagnostic techniques have become available. 
Unfortunately, in many cases these new discoveries have not yet trickled down to many 
of the providers on the frontline and a large amount of variation in care exists across the 
country. Because of the time sensitivity of sepsis, it is imperative that individuals 
working in the areas of healthcare who first come in contact with these patients have a 
clear understanding of the newest advances and resources available. In this thesis the goal 
is to first analyze the current protocols and standards of care for sepsis and then secondly 
consider new developments available both in the hospital and in prehospital emergency 
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medical services (EMS). From the current information, strategies and protocols based on 
improvement of patient outcomes, can be streamlined and optimized moving forward. As 
predicted, there is currently an incredibly large amount of variation and knowledge on the 
subject with some areas implementing very progressive protocols while others still lack a 
sepsis protocol all together. In general, the current consensus in the field is that rapid 
identification and initiation of treatment is the most important component to long term 
survival. Improvement of outcomes therefore relies on standardization of protocols with 
incorporation of education components for healthcare providers.  This aims to raise 
awareness and encourage utilization of the newest information and suggestions available. 
Increased interdisciplinary cooperation between prehospital providers in EMS and care 
providers in the hospital can also lead to improvement of recognition and treatment times 
for these patients. Future considerations were also examined that may potentially be 
applicable moving forward to improve these standards even further. There is a much 
opportunity available in each of these areas currently and progress is key to improving 
outcomes.    
 
 
 
 
 
 
 
 
vii 
 
TABLE OF CONTENTS 
 
TITLE…………………………………………………………………………………….............i  
COPYRIGHT PAGE………………………………………………………………………….….ii 
READER APPROVAL PAGE………………………………………………………………......iii  
ACKNOWLEDGEMENTS……………………………………………………………………...iv  
ABSTRACT………………………………………………………………………………………v 
TABLE OF CONTENTS……………………………………………………………………...…vii  
LIST OF TABLES………………………………………………………………………………..xi  
LIST OF FIGURES……………………………………………………………………………....xii  
ABBREVIATIONS…………………………………………………………………………..….xiii 
INTRODUCTION………………………………………………………………………………...1 
 DEFINITIONS…………………………………………………………………………...2 
 INCIDENCE……………………………………………………………………………..7 
 ETIOLOGY……………………………………………………………………………....8 
 PATHOPHYSIOLOGY…………………………………………………………………10 
 RISK FACTORS………………………………………………………………………...13 
CLINICAL PRESENTATION/MEANS OF RECOGNITION………………………………….14 
 VITAL SIGNS…………………………………………………………………………..14  
viii 
 
  TEMPERATURE VARIATION……………………………………………....14  
  HYPOTENSION……………………………………………………………….15  
  TACHYCARDIA AND TACHYPNEA……………………………………….16 
  END TIDAL CO2……………………………………………………………...16 
 LABORATORY VALUES……………………………………………………………..17  
  LACATE……………………………………………………………………….18  
  OTHER IMPORTANT LAB VALUES………………….……………………19 
CURRENT HOSPITAL MANAGEMENT STRATEGIES……...……………………………..19  
 INITIAL RESUSITATION…………………………………………………………….20  
 INFECTION SOURCE MANAGEMENT……………………………………….....….22  
 FLUID RESUSITATION…………………………………………………………....…23  
 VASOPRESSOR ADMINISTRATION…………………………………………….....24 
 BLOOD PRESSURE MONITORING………………………………………………...25 
 MECHANICAL VENTILATION/RESPIRATORY SUPPORT……………………...26 
 OTHER CONSIDERATIONS…………………………………………………….…...27 
HOSPITAL IMPLEMENTATION AND IMPROVEMENT MEASURES……………….…...27 
CURRENT EMS TREATMENT STRATEGIES………………………….…………………...29 
 LEVELS OF EMS CARE……………………………………………………………...30 
ix 
 
 CURRENT EMS SEPSIS PROTOCOLS…………………………………….……….37 
EMS IMPLEMENTATION AND IMPROVEMENT MEASURES…………………………..40  
 STANDARDIZATION/IMPLEMENTATION WITH HOSPITAL……………....…..40  
 DIAGNOSTIC TOOLS………………………………………………………………..41 
  LACTATE…………………………………………………………………….42  
  END TIDAL CO2………………………………………………………….....42 
  ALS MONITORING………………………………………………………....43 
  “SEPSIS ALERTS”…………………………………………………………..44 
 EMS TREATMENT OPTIONS………………...…………………………………….45 
  INTRAVENOUS FLUID ADMINISTRATION...…………………………..45 
  ANTIBIOTIC ADMINISTRATION………………………………………...46 
  VASOPRESSOR ADMINISTRATION……………………………………..47 
 OTHER CONSIDERATIONS………………………………………………….…….48 
  BLS AMBULANCE CARE…………………………………………….…....48 
  COMMUNITY PARAMEDICINE ………………………………….………49 
CONCLUSION………………………………………………………………………….……..50 
LIST OF JOURNAL ABBREVIATIONS………………………………………………….….52 
BIBLIOGRAPHY………………………………………………………………………….…..56 
x 
 
CURRICULUM VITAE………………………………………………………………………67  
xi 
 
LIST OF TABLES 
Table      Title     Page 
    1   Sequential (Sepsis-Related) Organ Failure Assessment Score 5 
    2   Breakdown of qSOFA Score      6 
    3   EMS Provider Scopes of Practice     32 
    4  Analysis of Sepsis protocols in 6 different States   38 
  
xii 
 
LIST OF FIGURES 
Figure      Title     Page 
1 Number of Sepsis Publications Per Year  3  
2 Flow chart of sepsis pathophysiology  12 
  
xiii 
 
ABBREVIATIONS 
AEMT   Advanced Emergency Medical Technician  
ALS   Advanced Life Support 
ARDS   Acute Respiratory Distress Syndrome 
BIPAP   Bi-level Positive Airway Pressure 
BLS   Basic Life Support 
BVM   Bag Valve Mask 
CD4 B   Cluster of Differentiation 4 B Cell (immune system) 
CD4 T   Cluster of Differentiation 4 T cell (immune system) 
CDC   Center for Disease Control 
CO2   Carbon Dioxide 
CPAP   Continuous Positive Airway Pressure 
CVA   Cerebrovascular Accident 
CXCL-8  Interleukin-8 
ED   Emergency Department 
EGDT   End Goal Directed Therapy 
EMR   Emergency Medical Responder 
EMS   Emergency Medical Services 
xiv 
 
EMTB   Emergency Medical Technician Basic 
EMTP   Emergency Medical Technician Paramedic 
ETCO2  End-Tidal Carbon Dioxide 
EUROBACT  European Society of Intensive Care Medicine 
FiO2   Fraction of Inspired Oxygen 
GCS   Glasgow Coma Scale 
GI   Gastrointestinal 
IBP   Invasive arterial blood pressure 
ICU   Intensive care unit 
IL   Interleukin 
IM   Intramuscular 
IN   Intranasal 
IO   Intraosseous   
IV   Intravenous 
IVF   Intravenous Fluid 
MAP   Mean Arterial Pressure 
NiBP   Non-invasive Blood Pressure 
xv 
 
NREMT  National Registry of Emergency Medical Technicians 
PaO2   Partial Pressure of Oxygen 
POC   Point of Care 
qSOFA  Quick Sequential Organ Failure Assessment 
SBP   Systolic Blood Pressure 
SC   Subcutaneous  
SIRS   Systemic Inflammatory Response System 
SL   Sublingual 
SOFA   Sequential Organ Failure Assessment 
SpO2   Peripheral Capillary Oxygen Saturation 
SSC   Surviving Sepsis Campaign 
TF   Tissue Factor 
TNF   Tumor Necrosis Factor 
US   United States of America 
UTI   Urinary Tract Infection 
WHO   World Health Organization 
 
 1 
 
INTRODUCTION 
 Sepsis and its associated disease processes, including severe sepsis, septicemia, 
and septic shock are currently recognized as one of the leading causes of death 
nationwide based on in-hospital mortality rates. A 2014 analysis of two patient groups, 
one from a northern California healthcare system, and another from a countrywide data 
set, estimates that anywhere between 34.7% to 55.9% of all inpatient hospital deaths 
occur with sepsis as a contributor.1 Despite this high mortality rate sepsis has long been 
ill defined and poorly researched relative to other major medical conditions such as 
cancer and heart disease. This is partly due to low awareness as well as vague, 
inconsistent definitions of sepsis. This has started to improve only very recently and 
primarily just in the last decade. According to a survey done by the Sepsis Alliance, only 
55% of all Americans had actually heard of sepsis in 2016.2 More shockingly this number 
represents an increase of more than 25 million people when compared to a similar survey 
done in 2015. In addition to the lack of sepsis awareness the same survey found that only 
28% could accurately identify symptoms of the condition.2 These improving numbers are 
a promising step in the right direction but substantial work can still be done to increase 
awareness as well as improve current treatment strategies for the future. WHO recently 
adopted a resolution that encourages all member states to aim for “reduction of the 
burden of sepsis through improved prevention, diagnosis, and management” as there are 
many areas around the world where awareness and recognition rates are significantly less 
than the previously noted US statistics.3 One of the most important aspects of treating 
sepsis and the focus of many campaigns worldwide has been the benefit of early 
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recognition and the prompt initiation of treatment.4 The majority of sick patients enter the 
hospital via the emergency department (ED) therefore it is the natural beginning of the 
screening process. The ED is also an opportunity for aggressive initial therapy options to 
be administered with the goal of decreasing mortality. One recent study showed that 
implementation of both a sepsis treatment algorithm as well as increased education of ED 
nurses led to both an increase in sepsis recognition of 21.5% as well as a decrease in 
patient mortality of 28%.5 This then shows that reduction in recognition and treatment 
time in the ED can be a major factor in combating sepsis mortality. A promising 
possibility then arises when considering prehospital medicine, particularly emergency 
medical services (EMS), as a potential area to further improve these metrics. Current 
studies show that identification of patients with sepsis in the prehospital environment is 
somewhat poor and that improved education and implementation of screening tools may 
increase effectiveness of prehospital providers in accomplishing early diagnosis.6 Efforts 
to integrate EMS detection and care with ED and definitive hospital interventions are 
more established and standardized in other time sensitive conditions such as acute 
myocardial infarction as well as cerebrovascular accident (CVA)/stroke and have shown 
to be effective in improving patient outcomes. 7,8 This thesis will attempt to examine the 
advances and information currently available regarding the treatment of sepsis in the pre-
hospital setting and how it can be improved moving forward.   
Definition:  
In 2016 the Third International Consensus (Sepsis-3), a global task force of 
diversified medical professionals, established an updated definition of the terms “sepsis” 
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and “septic shock”.9 The goal of this effort was to describe the advances that have been 
made in recent years as the medical and scientific research community have increased 
their focus on the study of sepsis. 9 A simple search of the term “sepsis” in the PubMed 
Database shows an exponential increase in the number of articles which mention or 
include the word especially in the past twenty years (Figure 1). This represents the 
enormous growth in data and therefore understanding available today. Due to the rapid 
and still evolving state of sepsis care worldwide, the Sepsis-3 collaboration was focused 
on standardizing this information and terminology available today so that the field is on 
the same page moving forward.9  
 
Figure 1: Number of Sepsis Publications Per Year Taken from PubMed's "Results By 
Year" tool with Sepsis as the search term. Data compiled from 
(https://www.ncbi.nlm.nih.gov/pubmed/?term=Sepsis, February 21,2019) 
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Figure 1: # of articles matching "Sepsis" Search Term by Year 
in Pubmed Database 
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Prior to Sepsis-3, the definition of sepsis stemmed from the first international consensus 
which laid down the groundwork in 1991 (Sepsis-1).9 These Sepsis-1 guidelines were 
based on the input of physicians worldwide and represented the first time sepsis had truly 
been categorized and consolidated into a standardized set of ideas and common 
terminology. The definition was expanded upon in 2001 by way of a task force with 
expanded diagnostic criteria (Sepsis-2) but the thinking had been mostly the same for 
more than 20 years.9 The old definition was focused primarily on recognition through 
diagnostic measures that focused on the host’s systemic inflammatory response (SIRS) to 
some sort of infection. Severe sepsis was defined in both Sepsis-1 and Sepsis-2 to be the 
point at which SIRS progressed to organ dysfunction.9 Septic shock is specified once 
hypotension persists despite standardized fluid resuscitation measures. This definition 
was found to be largely limiting by the investigators of Sepsis-3 and inaccurate when 
used to identify sepsis patients. The definition had both poor sensitivity and specificity 
when it came to classifying patients with sepsis versus those with other medical 
conditions.10,11 The new definition established by the members of Sepsis-3 defines sepsis 
as, “Life threatening organ dysfunction caused by a dysregulated host response to 
infection”. Organ dysfunction is then further categorized based on the sequential (sepsis-
related) organ failure assessment (SOFA) (Table 1). This score is mainly utilized in the 
intensive care unit (ICU) and ED settings to assess the severity of sepsis. Unfortunately, 
the SOFA score is not usable in EMS integration due to some of its parameters being 
unobtainable in the field.  
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Table 1: Sequential (Sepsis-Related) Organ Failure Assessment Score 
 Score 
System 0 1 2 3 4 
Respiration 
- PaO2/FiO2 mmHg 
(kPa) 
≥400 (53.3) ≤400 (53.3) <300 (40) <200 (26.7) with 
respiratory 
support 
<100 (13.3) with 
respiratory 
support 
Coagulation 
- Platelets, x 
10ଷ/µL 
≥150 <150 <100 <50 <20 
Liver 
- Bilirubin, mg/dL 
(µmol/L) 
<1.2 (20) 1.2-1.9 (20-
32) 
2.0-5.9 (33-
101) 
6.0-11.9 (102-
204) 
>12.0 (204) 
Cardiovascular MAP 
≥70mmHg 
MAP 
<70mmHg 
Dopamine <5 
or 
dobutamine 
any dose 
Dopamine 5.1-15 
or Epinephrine 
≤0.1 or 
Norepinephrine 
≤0.1 
Dopamine >15 
or Epinephrine 
>0.1 or 
Norepinephrine 
>0.1 
Central Nervous System 
- Glascow Coma 
Scale score 
15 13-14 10-12 6-9 <6 
Renal 
- Creatinine mg/dL 
(µmol/L) 
- Urine Output, 
mL/d 
<1.2 (110) 1.2-1.9 
(110-170) 
2.0-3.4 (171-
299) 
3.5-4.9 (300-440) 
 
<500 
>5.0 (440) 
 
<200 
Catecholamine values are based on dosing of µg/kg/min in one-hour intervals. Glasgow 
Coma Scale (GCS) is a standard means of assessing neurological function and is on a 3-
15 scale with a higher number representing more function. PaO2: Partial Pressure of 
Oxygen, FiO2: Fraction of Inspired Oxygen, MAP: Mean Arterial Pressure. Note In 
cardiovascular levels 2-4 MAP is no longer the parameter considered and it transitions to 
the level and type of vasopressor therapy administered. This is done because most 
patients scoring in the 2-4 range will require vasopressor therapy and then MAP cannot 
be considered as a true indicator of patient condition. This table was adapted from The 
Third International Sepsis Campaign Paper (Sepsis-3)9 
 
In addition to encouraged utilization of the SOFA score, Sepsis-3 also developed 
the qSOFA score which is designed to be much simpler and easy to use upon initial 
patient contact. The qSOFA can be used on every patient with a simple assessment. 
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Those with qSOFA scores of 2 or greater with suspected infection and therefore potential 
sepsis will quickly get a more thorough examination9. As opposed to the SOFA score, 
qSOFA scores can easily be used in the prehospital setting.  
Table 2: Breakdown of qSOFA score 
qSOFA score Assessment 
1 Hypotension (SBP less than or equal to 100mmHg) 
1 Tachypnea (greater than or equal to 22 breaths per minute) 
1 Altered mental status (GCS less than or equal to 14) 
If patient was found to have a qSOFA score of greater than 2 with suspected infection 
this indicates for potential sepsis and mandates further evaluation. Systolic Blood 
Pressure (SBP), Glasgow Coma Scale (GCS) is a standard means of assessing 
neurological function and is on a 3-15 scale with a higher number representing more 
function. Information taken from The Third International Sepsis Campaign (Sepsis-3).9   
 
The consensus found that if a SOFA score is greater than or equal to 2 this 
corresponds to a mortality risk of approximately 10%. Therefore, a qSOFA score of 2 is 
an appropriate threshold to begin diagnosis and subsequent initiation of sepsis treatments. 
 Furthermore, in the new definition, septic shock represents a more serious 
progression of sepsis. Specifically, the distinction between sepsis and septic shock occurs 
when hypotension progresses to the point of requiring medications such as vasopressors 
to maintain a mean arterial pressure (MAP) of ≥ 65 mmHg and a serum lactate level of ≥ 
2 mmol/L.9 These criteria were found to have in hospital mortality percentages in excess 
of 40% and were therefore considered by Sepsis-3 as a good threshold for the beginning 
of the “shock” state.9 This updated definition was designed to not only reflect advances in 
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understanding of the disease over the last 20 years but also foster unanimity as well as a 
common lexicon moving forward. This will enable researches and medical professionals 
to have a collective platform and terminology to further the efficiency and quality of 
sepsis treatment.9 
Incidence: 
Recognition of sepsis as a global health concern has led to many studies 
attempting to assess its global incidence and its widespread effect on people’s health.3 A 
study utilizing worldwide epidemiologic data estimated that over 31 million people are 
affected by sepsis each year.12 They also found that almost 20 million of those people 
would qualify as having signs of septic shock characterized by organ dysfunction and 
more significant risk of death. With mortality rates at 17% for sepsis and 26% for severe 
sepsis according to their data sets this predicts that approximately one in four people who 
acquire sepsis are likely to die as a result.12 This translates to upwards of 5 million deaths 
worldwide per year. The same study also highlights that these numbers are likely 
conservative as data from lower and middle income countries is often limited and 
difficult to collect.12 Furthermore, these developing countries may experience a greater 
number of cases with higher mortality rates due to decreased access to medical care, 
antibiotics, and poor living conditions. All of these factors make fighting the infections 
that lead to and cause sepsis more difficult.  
According to CDC data, sepsis did not even make an appearance on the list of 
leading causes of death in the US for 2016.13 Heart disease, cancer, accidental death, 
chronic respiratory disease, stroke, Alzheimer’s disease, diabetes, influenza/pneumonia, 
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renal disease, and suicide rounded out the top 10.13 Some of this can be attributed to 
categorization technicalities, for example influenza and pneumonia appear on the list and 
can often be the precursor to sepsis. In spite of its nonappearance on this list, statistics 
show that sepsis places a rather large burden on our healthcare system. In the face of 
sepsis only accounting for 3.6% of hospital stays in the US during 2013 it accounted for 
more than 6.2% of national healthcare expenditures with an estimated 23.663 billion 
dollars in aggregate healthcare costs.14 This makes sepsis the most expensive condition 
noted among US hospitals.14 The next closest condition, osteoarthritis, only accounts for 
16.520 billion dollars of national healthcare costs.14 When considering average cost per 
hospital stay, sepsis is almost double that of many other serious conditions and it is the 
number 1 cause of hospital readmissions for Medicare patients and the number 5 cause 
for privately insured patients in the US.15,16  
Etiology:  
As described above by the Sepsis-3 definition, sepsis occurs when there is a 
dysregulated response to an infection within the body. In this manner sepsis can be 
sourced from any type of local infection that goes untreated. The most common sources 
for sepsis include urinary tract infection (UTI), pneumonia, infections to abdominal 
organs, and infections in the pelvis.17,18 Respiratory infections including pneumonia are 
the biggest contributor by far accounting for nearly half of all sepsis cases.19 Due to this 
fact, sepsis is difficult to treat and can affect the body in many different ways depending 
on the original source and variety of infecting bacteria.  When patients diagnosed with 
sepsis are evaluated to determine the infecting organism, blood cultures are drawn and 
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sent to the lab for analysis. One of the most important considerations is the class of 
bacteria present as this guides which antibiotics will be most effective in treating it. One 
study found that the proportion of septic patients that were positive for gram-positive 
bacteria versus gram-negative bacteria was comparable. Gram-positive bacteria 
accounted for 47% of cases, whereas 62% were shown to have gram-negative bacteria, 
and another 19% were shown to be positive for fungus.18 The fact that these percentages 
exceed 100% indicates that patients may test positive for two or more types of pathogen. 
Data from this same study also suggests that site of infection, as well as organism, can 
have an effect on mortality rates.18 Other studies cite that Gram-positive infections are a 
more common cause of sepsis.  For example a retrospective data analysis of patient 
records from 1979-2000 showed that approximately 52.1% of sepsis cases were caused 
by gram-positive bacteria, while 37.6% were caused by gram-negative bacteria and only 
4.6% were fungal in nature over that time period.20 These statistics are taken from data 
sets that are somewhat older. It does indicate a large amount of variation in the 
microorganisms that are thought to influence the disease process.  
Specific antibiotic therapies are generally outside the scope of this thesis that 
focuses on EMS and ED integration of care. In these stages of sepsis treatment, emphasis 
is placed on quick identification and diagnosis as well as initial resuscitation techniques. 
This may include broad spectrum antibiotics which are covered later on. It is vital to 
begin the pathogen identification process during early initial evaluation. This includes 
collection of blood cultures as well as source control measures which will also be covered 
in other sections of this paper. 
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Pathophysiology: 
  One of the hallmarks of sepsis is a dysregulated immune response to an infection 
or infectious process. During normal infection, the body responds with a number of 
different immune based cells in order to control and eliminate the contagion. However, 
many of these cells become dysregulated in sepsis. The body’s first response to a 
localized infection is to recruit local or resident macrophages. Upon arrival at the site 
these macrophages release inflammatory factors such as chemokine ligand eight (CXCL-
8), tumor necrosis factor (TNF), and multiple interleukins.21 These signals are designed 
to be received by endothelial cells located in the walls of blood vessels. The cellular 
response to this signal is an upregulation of adhesion molecules on their luminal surfaces. 
These adhesion molecules recruit even more immune cells to enter the area from the 
bloodstream including neutrophils whose role is to further scale up the response via the 
release of more Interleukin (IL)-1 beta.21 Often in sepsis this response and the subsequent 
recruited cells become dysfunctional. 21 Elevated neutrophil levels are required to combat 
infection however they can become overactive in the case of sepsis leading them to 
potentially damage host cell tissues.22 It was found that early in sepsis a large amount of 
IL-10 is produced by neutrophils. This is initially beneficial but overproduction of IL-10 
leads to perpetuation of the dysregulated immune response.23  
Monocytes are another important immune cell recruited to sites of infection. They 
are responsible for reduction of inflammation, perpetuation of healing, and clearing of 
pathogens via phagocytosis.21 In sepsis, the function of these cells is also altered by 
multiple mechanisms and signaling cascades that are not completely understood.24 In 
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many models it has been shown that monocytes have a diminished ability in sepsis to 
release proinflammatory cytokines due to endotoxin tolerance.25 This leads to lower 
levels of antigen presentation and subsequently lower levels of antigen specific 
lymphocyte production while simultaneously promoting inflammation therefore 
worsening the dysregulated immune response and infection.25  
Further complicating sepsis is a reduction in the effectiveness of the patient’s 
adaptive immune system which typically recognizes and coordinates defense against 
specific pathogens. This is due to a drop in the number of lymphocytes caused by 
apoptosis of both CD4 T cells and B cells. It is suspected that this is why patients 
experience a decrease in immune response once sepsis progresses to a certain point.26 The 
next step in the sepsis pathway is related to dysregulated or dysfunctional coagulation 
pathways. This is primarily caused by disruption of the pathways via inflammatory 
cytokines that lead to an increase in tissue factor (TF) expression and down regulation of 
antithrombin, protein C system and fibrinolysis. Variation in the levels of these factors 
leads to an environment that favors coagulation.21 When TF is upregulated it leads to 
upregulation of both extrinsic and intrinsic coagulation pathways. Antithrombin, which 
usually inhibits thrombin and clotting is also down regulated.27  Together all of these 
factors come together leading to inflammation, immune system dysregulation/ 
suppression, and eventual systemic organ failure and hypotension. This process is 
outlined in Figure 2. For these reasons many of the novel therapies in development look 
to specifically take advantage of these pathways and correcting their dysfunction to 
combat the progression and mortality of sepsis.21,25  
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Figure 2: Flow Chart of Sepsis Pathophysiology: Chart outlining the general cellular 
processes and mechanisms that occur to create sepsis conditions in patients. Information 
gathered from multiple sources.21–27 
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Risk Factors:  
 When considering risk factors of sepsis anything that increases a patient’s chances 
of getting an infection or diminishes a patient’s ability to combat an infection may be 
considered. In particular, the elderly population is at an increased risk of sepsis as they 
have increasing immunosenescence, as well as a generally higher number of 
comorbidities. Additional diagnostics are hampered due to many of the signs and 
symptoms being attributed to these other conditions.28 Elderly people also live in places 
such as nursing homes, or assisted living type facilities where it may be easier to obtain 
an infection.29 Infections such as UTIs and respiratory tract infections, two of the most 
common infections that lead to eventual sepsis, are found in increased prevalence in the 
elderly population as well.30 Those with compromised immune systems also tend to be at 
higher risk as their immune system cannot prevent the spread of the infection to a 
systemic level. This will eventually lead the patient to septic shock.  
A 2004 study found that sepsis is a common complication associated with cancer 
and that cancer patients see an increase in sepsis incidences due to the patients’ decreased 
immune function. It was also found by the same study that 8.4% of all cancer deaths 
occur as a result of sepsis complications.31 Diabetic patients are also thought to have an 
increased risk of contracting sepsis as a result of the effects the condition already places 
on the immune and inflammatory response system. This is further complicated by 
decreased healing ability and the increased possibility of late identification of local 
infections.32   
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CLINICAL RECOGNITION/MEANS OF RECOGNITION 
Sepsis is characterized primarily by an infection that progresses to the point of 
affecting normal organ function.9 As this is the nature of the illness most diagnostic 
measures aimed at allowing early recognition are vital signs and lab tests that identify 
infection or organ dysfunction. As the signs of sepsis can vary depending on what organ 
system is affected it is challenging to derive one or two definitive measures to identify it. 
Originally SIRS was used as a measurement for sepsis but limitations in specificity were 
found.11 SOFA and qSOFA scores are now the new standard for evaluation of sepsis 
patients in the hospital. These scores address the limitations of the previous SIRS criteria 
by considering more body systems and potential signs.  (Table 1 and Table2).  
Vital Signs:  
Temperature Variation: One important vital sign often considered as part of 
solving the sepsis puzzle is internal body temperature. Temperature changes are widely 
accepted as a sign of underlying stress to the body, thermoregulation imbalance, and 
possible infection.33 A worldwide cohort study on the epidemiology and determinants of 
outcomes of hospital acquired blood stream infections in intensive care (EUROBACT) 
survey conducted of ICUs in different parts of the world found that 93% of respondents 
would utilize a new change in a patient’s internal body temperature as a trigger to 
perform new blood cultures and tests, demonstrating that it can be an effective means of 
raising concern of a new infectious process.34 Despite this it should not be utilized as a 
means of diagnosing sepsis or general infection without the supporting evidence of other 
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factors. Some studies have found that pyrexia (elevated temperature) can manifest due to 
a number of conditions not all of which include infection.35 In addition to these 
considerations other research by Kushimoto et al. also shows that some septic patients 
will present with hypothermia in contrast.36 In these patients there is a strong indication 
that this particular finding signifies an even higher mortality rate than normal. Patients 
with an internal body temperature less than or equal to 35.5 degrees Celsius see in-
hospital mortality rates rise to 52.2% according to their study.36 It is worth noting that 
this study was done with patients who had already been diagnosed with both sepsis and 
hypothermia as they were examining hypothermia as a means of predicting in-hospital 
mortality, rather than sepsis incidence.   
Hypotension: Hypotension is largely regarded as one of the classic, telltale signs 
of sepsis when coupled with other common signs and symptoms discussed in this section. 
Despite being such an integral part of sepsis diagnosis and supportive treatment, the 
causes of hypotension are not completely understood and are under active investigation. 
A review done in 2014 suggests that although it is likely a combination of factors, 
cellular dysfunction in both the immune system and in the local vasculature typically 
disrupts the body’s normal ability to control microcirculation in the periphery.21 This can 
lead to porous vessels and dilation. This dysfunction occurs specifically in lymphocytic, 
phagocytic, and endothelial cells and when coupled with an increase in soluble 
inflammatory mediators as well as coagulation cascade dysfunction the body’s normal 
ability to prevent hypotension is inhibited.21 A study published in 2015 by Sato and Nasu 
also showed that the increase in systemic endotoxins and cytokines typical of sepsis can 
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lead to sepsis induced cardiomyopathy, which decreases ejection fraction and leads to 
ventricular dilation.37 This could also contribute to hypotension in septic patients. No 
matter the cause, hypotension has been identified as a critical marker of sepsis and is 
included in the large majority of current guidelines for diagnosis both in the ED and in 
EMS. The new criteria place particular emphasis on maintain a MAP of 65 mmHg or 
greater as this represents end organ perfusion in a much more complete metric as opposed 
to metrics based on systolic or diastolic pressures. 
Tachycardia and Tachypnea: Tachycardia and tachypnea can occur in sepsis 
secondary to hypotension. As perfusion pressure falls in the body peripherally, the natural 
response is an attempt to improve cardiac output by increasing heart rate (tachycardia). 
Similarly, as perfusion falls and oxygenation of tissues decreases paired with an increase 
in CO2 and subsequent acidic conditions in the blood, the body attempts to compensate 
by increasing respiratory rate resulting in tachypnea. Tachycardia and tachypnea can also 
be caused by a fever which commonly occurs in the presence of infections as previously 
discussed. These two vital signs are also associated with respiratory infections, the most 
common cause of sepsis.30 One 2017 study found that persistent tachypnea and 
tachycardia can be associated with increased mortality in the ED. 38  
End tidal CO2 Monitoring/Capnography: End tidal CO2 (EtCO2) monitoring is 
one of the novel vital signs that is gaining traction as a quick non-invasive and relatively 
reliable marker of potential sepsis and other metabolic dysfunction in the body. EtCO2 is 
a measurement of the partial pressure of CO2(PCO2) in the air a person is exhaling. It is 
a product of cardiac output, pulmonary function, and the metabolic status of the patient. 
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Pulmonary function, metabolic status and therefore PCO2 can be affected two-fold in 
sepsis due to the existence of decreased cardiac output as well as metabolic dysfunction 
associated with decreased perfusion and the actual infection. 21 As sepsis worsens, blood 
lactate levels increase and metabolic acidosis ensues. Due to the acid base buffer system 
which utilizes exhaled CO2 as a way to regulate acid base balance, patients 
hyperventilate as a compensatory mechanism to breathe off extra CO2 and restore normal 
pH levels.39 Thus EtCO2 can be measured and accurately identifies both metabolic 
acidosis40 and sepsis.41 A study done by McGillicuddy et al also found that EtCO2 
monitoring shows a positive correlation between lactic acidosis and higher SOFA scores, 
the gold standard of diagnosing sepsis.42 Furthermore when these readings are compared 
to mortality rates and lactate production they show a significant association and therefore 
may be usable as an early predictor of in hospital mortality for patients with sepsis.43 In 
light of the close associations with other common indicators of sepsis, as well as its 
ability to predict hospital mortality, end tidal CO2 monitoring is becoming standard 
across the board when assessing patients. Normal readings of EtCO2 for a healthy patient 
are typically between 35-45 mmHg whereas sepsis patients are typically found to have 
EtCO2 readings of < 35mmHg.41 Mortality increases as this number decreases further 
due to a lower value representing increased hyperventilation and compensatory effort by 
the patient to correct underlying metabolic acidosis.41 It is also regarded as a non-invasive 
yet accurate way to assess pCO2 as it can be done with a nasal cannula.44 
Laboratory Values: 
 18 
 
Lactate/ Lactic Acid: The new definition and criteria for sepsis put forth by the 
third international consensus includes serum lactate levels of >2mmol/L as a means of 
diagnosing sepsis and therefore it is a focus moving forward.9 Lactate is produced by 
cells when they experience conditions of hypoxia and are forced to go through anaerobic 
metabolism. Sepsis commonly produces hypoxic conditions either due to inflammation or 
hypotension.45 When vasopressors are applied it can also increase lactate further due to 
vasoconstriction and subsequent hypoxia. When septic shock leads to decreased organ 
function in the liver and kidneys it also increases lactate levels, as this is normally where 
lactate is cleared.46 Likely due to a combination of these factors, lactate has been shown 
to be a very reliable means of assessing sepsis patients when coupled with BP, EtCO2, 
heart rate, and other assessments.47 Also advantageous is the ease at which a lactate 
reading can be obtained at the bedside of the patient. Handheld meters that work similarly 
to glucometers utilized in blood glucose measurements are becoming much more 
commonplace in hospitals. Theses handheld lactate meters utilize a small amount of 
blood obtained from a finger prick or IV start in order to analyze blood lactate levels and 
can produce a reading in under a minute.48 The speed and frequency at which these 
readings can be obtained should help providers to afford better recognition and treatment 
based on real time data from the patient. The cost of these meters and point of care (POC) 
lactate monitoring has also been proven to be largely cost effective. A study published in 
2016 found that on average normal lactate monitoring via standard laboratory methods 
costs approximately $33.20 per patient whereas the POC lactate monitoring cost 
approximately $39.53 per person.49 This increase of $6.33 per patient produced an 
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improvement of 1.07 additional quality adjusted years in patients proving that POC 
lactate is a worthwhile, meaningful, and cost effective treatment in the treatment of 
sepsis.49 
Other Important Lab Values:  
When a septic patient arrives at the ED, they often undergo a full panel of blood 
tests which includes many other individual values that can help diagnose specific organ 
dysfunction and other problems. A few lab values such as procalcitonin and C-reactive 
protein have also gained attention as potential indicators of sepsis and have seen degrees 
of initial testing and use in the ICU. However, they are not currently commonplace.50 In 
addition, these values are not able to be used in the prehospital or urgent setting at the 
moment and therefore they are currently beyond the scope of this thesis. 
CURRENT HOSPITAL MANAGEMENT STRATEGIES: 
As established previously in this thesis, sepsis research has exploded over the past 
decade (Figure 1). As a result, many healthcare systems have started to adopt protocols 
that utilize many of the research breakthroughs to aid in the care of patients. Despite this, 
there is still a large amount of variation in treatment protocols, algorithms, diagnostic 
criteria, and standard interventions. These also vary depending on the location and 
healthcare organization being considered. Due to the lack of standardization many places 
such as New York State have started mandating that all hospitals must adopt some form 
of sepsis protocol as well as systems for reporting rates of sepsis diagnosis and 
compliance with the mandate.51 This response is aimed at many healthcare systems which 
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are still lagging behind in the treatment metrics of sepsis laid down by Sepsis-3.  Failure 
to implement these new practices is leading to decreased sepsis recognition and therefore 
increased mortality rates despite the fact that a large consensus among care providers of 
the “best practices” has been reached.52 Most healthcare agencies with newer guidelines 
have taken the suggestions from the Surviving Sepsis Campaign and utilized the new 
definitions set forth in the previously reviewed Third International Consensus.9,52,53 
Therefore the following sections exploring current hospital treatment are based primarily 
on these two guidelines.  
Initial Resuscitation:  
Initial resuscitation recommendations are typically associated with early recognition and 
assessment, followed by collection of blood cultures and lactate, and then finally 
preliminary treatments including broad spectrum antibiotics as well as fluid resuscitation. 
Commonly this is grouped into something referred to as a care bundle.52  The initial fluid 
bolus recommendation is 30mL/kg of crystalloid fluid, such as sodium chloride solution 
at 0.9% concentration (normal saline), within the first 3 hours. This gives clinicians 
enough time to finish specific assessments and a treatment plan without delaying the 
initiation of treatment.53 It is also accepted that after initiation of interventions to support 
blood pressure, the goal should be maintaining a MAP above 65mmHg.54,55 Finally, is a 
good indicator of sepsis and is seen as a guide to assessing severity and determining 
treatment aimed at decreasing mortality.56 Blood cultures are typically taken at the same 
time as it is necessary to obtain the results of both of these tests as soon as possible. This 
prevents delay of therapy and begins the analysis process so that further down the 
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treatment algorithm more specific end goal directed therapy can take over. It is also 
suggested that these readings be taken prior to the initiation of treatment so that an 
accurate reading of initial disease severity, as well as a clear picture of the infecting 
organism, are obtained prior to the effects of intervention.52 One study found that 
sterilization of these cultures can occur only shortly after antibiotic administration, and 
therefore there should be a balance of attempting to obtain these cultures before 
administration of interventions while at the same time not delaying this treatment. 57 
Obtaining blood cultures earlier is also shown to lead to quicker phasedown of broad-
spectrum antibiotics.58–60 This is especially beneficial in decreasing overuse of antibiotics 
that are nonspecific or ineffective on a particular infection. As a result there is a smaller 
chance of developing multidrug resistant organisms, patients tend to see better outcomes 
with less side effects, and the overall cost and burden on the healthcare system is 
decreased.59,61  The final part of the initial care bundle is the administration of broad 
spectrum antibiotics which also becomes a careful balance for clinicians. The Surviving 
Sepsis Campaign’s recommendation is to consider all of the following when choosing an 
antibiotic treatment strategy: “the site of the initial infection and the typical pathogen 
profile associated with it, the presence of immune system suppression or malfunction in 
the specific patient, typical pathogens seen in the facility, their resistance patterns, and 
the other comorbidities of the patient.”52 Although many are wary of the negative effects 
of over-prescribing antibiotics and creating “superbugs”, the SSC suggests that over 
inclusiveness, when it comes to prescribing broad spectrum antimicrobials in sepsis, is 
suggested due to the disease’s severity.52,62 The most common of these initial dosing 
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regimens is a carbapenum based antibiotic or an extended range penicillin combined with 
a beta-lactamase inhibitor. These are also commonly paired up with cephalosporin 
specifically one that is of third generation or higher.52 This seems to cover most 
infections but should be adjusted based on specific information about each case.52 It is 
also worth noting that this combination therapy is recommended for initial treatment but 
that it is also beneficial for the patient to move to more specific therapy once the 
pathogen has been properly identified as prolonged antibiotic therapy can lead to death.63  
Antibiotic/antimicrobial administration is often grouped together with fluid resuscitation 
and other initial therapies as there is some evidence that antibiotics alone cannot combat 
sepsis entirely but that appropriate deployment of them with other interventions leads to 
lower mortality rates around 13%.64 
Infection Source Management:  
After this initial treatment bundle or strategy has been implemented, the next step is 
addressing the source of the infection, as well as continuation of targeted antibiotic 
therapy, and continual support of the patient hemodynamically. Managing the source of 
the infection is not always applicable but is vastly important when it comes to combating 
sepsis that arises from localized sources of infection such as abscesses, necrotic tissue, 
gastro-intestinal (GI) perforations, ischemic bowel, or kidney infections such as 
pyelonephritis from obstruction. These conditions cannot be treated merely by 
medication or supportive measures. They often persist unless physical intervention such 
as drainage, surgery, or debridement is done.52 The timetable at which this takes place is 
very critical in patients and delays in implementation of source management can lead to 
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increased mortality. One prospective observational cohort study in Germany found that 6 
hours should be the goal for surgical source control and that anything past this 
significantly increases mortality in patients of approximately 10%.65 Another study 
looking specifically at patients with septic shock as a result of GI perforation also found 
that surgery after 6 hours represents a large increase in mortality. This study actually had 
100% mortality rate if source control was not done before 6 hours, and better outcomes 
were associated with quicker surgical intervention.66  
Fluid Resuscitation:  
As previously covered fluid resuscitation is typical among initial treatment of sepsis 
patients. However, there is less evidence and therefore consensus in terms of 
recommending fluid resuscitation after initial treatment bundles have been completed. It 
was found in a retrospective case study that in many cases where fluid resuscitation 
efforts caused positive fluid balance or volume overload patients seemed to experience 
higher mortality and worse outcomes therefore clinicians should be cautious to over 
administration of fluid post initial treatment.67  On top of the timing for fluid 
administration, there is also some investigation being done into the possibilities of 
different types of fluid being utilized. Most studies when comparing different choices for 
fluid resuscitation have found that crystalloid fluids are the gold standard. Albumin has 
also been considered as an equivalent means of resuscitation due to a multicenter open 
label trial in 2014 found that there is no difference in 28 or 90-day mortality when 
patients are given albumin and crystalloid therapy as opposed to just crystalloid.68 
Despite this albumin has not yet made its way into many treatment protocols as studies 
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have shown no definitive benefit to simple crystalloids.  Other fluids have also been 
tested but are currently not recommended as they have been found to be less helpful or 
even harmful when compared to standard crystalloids in septic patients.52  
Vasopressor Administration:  
When initial fluid resuscitation is not enough to restore normotensive blood pressures in 
patients experiencing septic shock, clinicians often turn to vasoactive agents as a means 
to counteract the hypotension. This is not required in all cases but is commonplace to 
avoid requiring administration of excessive amounts of fluid that could potentially cause 
complications as noted in the previous paragraph. In this class of drugs there are multiple 
options including but not limited to epinephrine, dopamine, norepinephrine, dobutamine, 
vasopressin, and levosimendan.69 The two most widely used and studied, by far, are 
norepinephrine and dopamine with each offering slightly different effects.70  
Norepinephrine has been found to be beneficial in the majority of patients due to its 
higher specificity in increasing vasoconstriction and increasing systemic vascular 
resistance with little effect on heart rate and stroke volume, compared to dopamine. A 
separate meta-analysis was able to show that norepinephrine has a significantly lower risk 
profile of around 11% in sepsis treatment. The study stated that, “when compared to 
dopamine, norepinephrine produces a greater reduction in mortality, cardiac events, and 
heart rate while being more effective in raising systemic vascular resistance”, showing 
that it is all around a better medication for sepsis in most situations.71–73 In a review of 
multiple trials epinephrine, vasopressin, phenylephrine, and terlipressin were all 
compared to norepinephrine and dopamine in terms of effectiveness in reducing mortality 
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in septic shock.  These trials found that there is no significant change in mortality in any 
of these medications when compared to the two typical first line drugs of norepinephrine 
and dopamine.73 As a result of this norepinephrine and dopamine are still recommended 
as they are the most focused of all of these medications. The same study also showed that 
norepinephrine should be utilized over dopamine when they are directly compared to one 
another due to less side effects associated with a more focused mode of action 
hemodynamically. Norepinephrine was shown to have approximately half the risk of 
causing other complications such as cardiac arrhythmias among other effects and is 
therefore still the recommendation for a first line vasopressor in sepsis.73 Other 
vasopressors are viable options in cases when norepinephrine is unavailable or 
contraindicated however they are generally regarded as less favorable. There are certain 
cases where other vasoactive agents such as dopamine, dobutamine, and levosimendan 
are theorized to be more favorable to treat some sepsis cases however these incidences 
are generally recorded in a low number of patients and the data available to support their 
alternate use comes from only a few small trials. Due to its complexity, this usually is up 
to the individual discretion of the treating physician and not outlined in hospital 
protocols.52  
Blood Pressure Monitoring:  
Once the initial resuscitation of a septic patient has begun and the patient has been 
admitted to the ICU for continued treatment and recovery it is also recommended by the 
SSC that a central arterial catheter be placed so that blood pressure may be monitored by 
IBP (Invasive Arterial Blood Pressure) vs NIBP (Non-Invasive Blood Pressure). IBP is 
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generally regarded as a more accurate method of measuring blood pressure in real time 
and possesses less possibility for inaccuracy. A 2013 study of ICU patients found that 
there is a significant discrepancy in pressures when comparing IBP and NIBP in terms of 
systolic and diastolic measurements. They found typically that NIBP reading read lower 
than true IBP in situations of hypertension whilst reading higher than IBP in situations of 
hypotension. The study also revealed that despite this discrepancy there were not 
significant differences in MAP between the two methods and suggested this as an 
improved marker of patient condition as opposed to systolic and diastolic readings 
especially when utilizing NiBP.74 As covered previously in the initial resuscitation 
section the SSC has already recommended that MAP be the standard vital sign in sepsis 
target blood pressures as opposed to systolic and diastolic readings. This is especially 
important to consider in areas where IBP may not be available or feasible such as 
prehospital EMS. IBP may also be beneficial as it provides a continuous real time reading 
of the patient’s blood pressure as opposed to a NIBP reading which takes time to be 
acquired. Real time IBP scores may better be able to show the results of interventions 
quickly and may help to lead to quicker adjustments in medication and management. In 
terms of EMS management some states allow advanced life support (ALS) ambulances to 
monitor IBP however it is not a standardized protocol in most areas.  
 Mechanical Ventilation/Respiratory Support:  
The SSC also makes several recommendations when it comes to mechanical ventilation 
and sedation of patients with suspected acute respiratory distress syndrome (ARDS) and 
sepsis. These specific considerations are outside the scope of this paper as these decisions 
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typically only come into practice further down the sepsis care algorithm after the patient 
has left EMS and ED care. Generally care in early treatment revolves around supporting 
the patient’s ventilation and oxygenation via supplemental oxygen administration and 
supportive ventilation via simple BVM or CPAP and does not extend to mechanical 
ventilation or sedation.52  
Other Considerations:  
The SSC also identified many potential management techniques and interventions that it 
did not recommend, as of yet, due to lack of, or conflicting evidence. These include 
administration of corticosteroids, blood products, immunoglobulins, anticoagulants, and 
bicarbonate.52  
HOSPITAL IMPLEMENTATION AND IMPROVEMENT MEASURES: 
As hospitals evolve in their treatment of sepsis the newly set forth SSC guidelines 
and the newly established Sepsis-3 definitions are the primary guiding factors when it 
comes to setting up new protocols in individual healthcare systems. Although the SSC is 
very through in its considerations and suggestions it is ultimately up to hospitals to 
implement their own protocols. The most effective means of combating high mortality 
rates is improving recognition and time to initiation of end goal directed therapy (EGDT). 
This has been the primary focus of new sepsis treatment systems. Naturally this has led to 
many new protocols and efforts to change the way medical professionals approach sepsis 
upon first diagnosis and treatment. Due to its unique role in the hospital as the point of 
entry for most patients, the ED is often targeted as the area where many of these many of 
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these new strategies can potentially be most effective. Studies have found that on average 
one in every three sepsis patients initially presents through the emergency department.75 
Another study in Utah found that nearly 2% of all patients that present to the ED have 
sepsis.76 So far measures to increase recognition and initial diagnosis have proven to be 
effective in the ED. One study at a tertiary care ED found that simple implementation of 
a standard sepsis treatment algorithm based on SSC suggestions, paired with improved 
nurse education, led to a nearly a 28% reduction in mortality.5 This treatment algorithm 
involved rapid diagnosis, lactate, blood cultures, labs, broad spectrum antibiotics, and a 
multidisciplinary team approach. The results showed that mortality rate decreased from 
18.4% to 13.2% as a result of the education and algorithm. Additionally, both compliance 
with SSC 3-hour bundle recommendations as well as the number of patients recognized 
to have sepsis increased significantly.5 A similarly designed study done in the 
Netherlands which also looked at nurse education, implementation of SSC care bundles, 
and a sepsis protocol found similar results with care bundle compliance increasing from 
3.5% to 12.4%. Some individual measurements such as serum lactate saw even larger 
increases in compliance from 17% to 78%.77  A third retrospective chart review also 
found that implementation of similar protocol measures and nurse initiated protocols led 
to higher compliance with SSC bundles. They also were able to find that bundle 
compliance with measurements such as serum lactate and blood cultures approached 
much higher compliance than interventions requiring coordination between multiple 
health care professionals. The researchers suggested further integration of 
interdisciplinary teams in order to further increase bundle compliance which can be 
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implemented between nurses and physicians but also between the hospital and EMS. This 
study found no difference in mortality which may be a result of intervention compliance 
not increasing as drastically as diagnostic compliance.78  
Before the recommendation by the SSC and Sepsis-3 EtCO2 and lactate 
monitoring had not been considered as widely in sepsis management. As an example of 
newer hospital sepsis procedures, the policies put forth at Baylor University Medical 
Center that revolve around two distinct care bundles. First, within the initial 3 hours and 
the second within the first 6 hours of care post suspicion and activation of sepsis protocol. 
The first 3-hour bundle includes the diagnostic tools of serum lactate as well as blood 
cultures, the initial treatment of a crystalloid fluid bolus, and broad-spectrum antibiotics. 
If patients do not improve the 6-hour bundle is implemented which is similar to the 3-
hour bundle in terms of diagnostic tools but represents a more targeted and aggressive 
strategy when it comes to intervention. Accompanied with the recommendation of these 
bundles is a large amount of staff education and supplemental protocol flow charts with 
suggestions of next steps and interventions.79 Other institutions such as Massachusetts 
General Hospital have attempted to implement computer algorithm based sepsis alert 
systems that trigger warnings to nurses and physicians when the lab results and vital signs 
of a patient meet patterns associated with typical sepsis presentations.80   
CURRENT EMS TREATMENT STRATEGIES: 
Many of the previously outlined studies highlight that increased education, 
focused on identifying sepsis quickly and accurately is one of the best means of 
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combating it. As covered, this places a lot of emphasis on initial care in the emergency 
department which has shown improvement based on many of the methods covered in the 
previous section. When considering further actions that can be taken, Emergency Medical 
Services (EMS) has been considered one of the areas of potential further improvement. A 
2010 study analyzing Medicare data estimated that approximately 36.7% of all patients 
who present to the ED arrive via EMS, representing a sizable portion of ED admissions.81 
When considering other time sensitive conditions, such as myocardial infarction and 
acute cerebrovascular accident (CVA)/stroke, implementation of increased education and 
specific protocols in EMS have shown benefit. These measures are focused primarily on 
identification and initiation of early treatment along with early hospital alert procedures 
and have led to improved outcomes and lower levels of mortality or serious 
impairment.7,82 Another prospective study, also published in 2010 established that 
patients with serious infections such as sepsis or septic shock arrived at the hospital via 
EMS 34.2% of the time. This percentage is in line with the amount transported in 
general.83 The same study also found that patients who met criteria for sepsis protocols 
within the ED were more than likely those who arrived via EMS with 61.1% of these 
patients having had initial EMS care.83 This suggests that higher acuity Septic patients are 
more than likely those who utilize EMS.83  EMS crews spend large amounts of time with 
these patients (i.e. upwards of an hour).84 Despite this large percentage, current 
recognition of sepsis via EMS is poor. One pilot study utilizing lactate meters and other 
criteria only showed an accurate severe sepsis recognition rate of 47.8%.85  
Levels of EMS care: 
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Similar to sepsis the nationwide EMS system has seen a large evolution over the last two 
decades. Historically, EMS agencies have been managed independently at the regional 
and state level with these smaller governing bodies handling everything in house. This 
includes all licensing, training, establishment protocols and standards of care, regulation, 
and logistical concerns of a particular geographical area. This meant that in many cases 
the established standard of care in terms of any particular disease including sepsis, varied 
largely in different parts of the country or even in different parts of the same state. Again, 
similar to that of sepsis treatment, there has been considerable effort to standardize and 
improve EMS care across the country through best practices. The National Registry of 
Emergency Medical Technicians (NREMT) which was established in the 1970s, has 
slowly started to integrate itself into all states across the country and has nationalized 
many aspects of the field.86 Currently all initial training, licensing examinations, 
recertification and levels of EMTs are defined by the NREMT. They also suggest certain 
protocols and best practices, but still leave individual protocol decisions and the exact 
implementation of care to regional and state agencies. Despite this, most states have 
come to accept the four standardized levels of care that exist within EMS put forward by 
the NREMT. These include Emergency Medical Responder (EMR), Emergency Medical 
Technician- Basic (EMT-B), Advanced Emergency Medical Technician (AEMT), and 
Emergency Medical Technician- Paramedic (EMT-P) with each representing a different 
level of education as well as capability. EMR level EMS personnel are trained in very 
basic lifesaving first aid as well as CPR. Those registered as EMRs are not usually 
individuals staffing ambulances but other first responders such as firefighters or police 
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officers. Ambulances are also broken into two separate classes Basic Life Support (BLS) 
and Advanced Life Support (ALS). BLS ambulances are typically staffed by EMT-B 
personnel who represent the entry level EMT. These individuals are trained in CPR as 
well as numerous life saving techniques and are equipped to do basic lifesaving 
maneuvers and administer select lifesaving medications such as epinephrine auto-
injectors and nasal narcan. EMT-B represent the bulk of EMTs nationwide with 283,143 
individuals occupying this rank with the total certified in all ranks of 416,174.86 ALS 
ambulances, typically staffed by EMT-Ps and occasionally 1 AEMT are equipped to 
handle more complex medical emergencies and are capable of placing IVs, advanced 
cardiac monitoring and intervention, intubation, and more. For a more through overview 
of the varying abilities see Table 3 which is based on the Massachusetts Specific 
Protocols.87 As previously stated protocols are state dependent but generally follow 
closely to this format as it mirrors the NREMT guidelines.    
Table 3: EMS Provider Scopes of Practice  
Procedures and 
Interventions 
Level of Care 
Access and medication 
administration 
EMR EMT-Basic AEMT EMT-
Paramedic 
IM Auto-Injector 
medication 
administration 
Yes Yes  Yes Yes 
Blood Products No  No  No  Yes (IFT) 
Inhalation  No  Yes (via MDI) Yes Yes 
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Intramuscular access 
(IM) 
No  Yes (via extra 
training and 
medical 
director 
approval) 
Yes  Yes 
Intraosseous access (IO) No No  Yes  Yes 
Intravenous access (IV) No  No  Yes  Yes 
IV Medication Pump No No  No Yes 
Oral medication 
administration 
No Yes Yes  Yes 
Intranasal medication 
administration (IN) 
Yes Yes Yes Yes 
Rectal Medication 
administration 
No  No  Yes (with 
EMT-P 
assistance) 
Yes 
Subcutaneous (SC) 
Medication 
Administration 
No  No Yes Yes 
Sublingual Medication 
Administration (SL) 
No Yes (May 
assist patient 
in Self 
administration) 
Yes Yes 
Central Line 
Maintenance  
No No No Yes (IFT) 
Peripheral Venous 
Access  
No  No Yes Yes 
Airway/Respiratory 
Procedures 
    
Bag Valve Mask (BVM) Yes Yes Yes Yes 
End Tidal Capnography  No No Yes Yes 
Chest Tube Maintenance  No No No Yes (IFT) 
Abdominal Thrusts 
/Heimlich (Airway 
Clearing) 
Yes Yes Yes Yes 
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Continuous Positive 
Airway Pressure (CPAP) 
No Yes (with 
EMT=P 
assistance) 
Yes (with 
EMT=P 
assistance) 
Yes 
Endotracheal Intubation  No No No Yes 
Endotracheal Suctioning  No No Yes Yes 
Supraglottic Airways  No No Yes Yes 
Nasogastric/Orogastric 
Tube 
No No No Yes 
Nasopharyngeal Airways 
(NPA) 
No Yes Yes Yes 
Nebulizer Treatments  No Yes (via extra 
training and 
medical 
director 
approval) 
Yes Yes 
Needle Decompression  No No No Yes 
Oral Suctioning  No Yes Yes Yes 
Oropharyngeal Airway 
(OPA) 
Yes Yes Yes Yes 
Oxygen Administration  No Yes Yes Yes 
Pulse Oximetry No Yes Yes Yes 
Tracheostomy 
Maintenance 
No Yes Yes Yes 
Mechanical Ventilator 
Operation 
No No No Yes (IFT) 
Cardiac Interventions 
and Management 
    
12-Lead EKG placement  No Yes (with 
additional 
training while 
assisting 
EMTP) 
Yes (with 
additional 
training while 
assisting 
EMTP) 
Yes 
4 Lead EKG placement  No Yes (with 
additional 
training while 
Yes (with 
additional 
training while 
Yes 
 35 
 
assisting 
EMTP) 
assisting 
EMTP) 
Cardiopulmonary 
Resuscitation (CPR)  
Yes Yes Yes Yes 
AED Defibrillation  Yes Yes Yes Yes 
Manual Defibrillation No No No Yes 
Interpretation of 12-Lead 
EKG  
No No No Yes 
Interpretation of 4 Lead 
EKG 
No No No Yes 
Synchronized 
Cardioversion 
No No No Yes 
Transcutaneous Pacing No No No Yes 
Targeted Temperature 
Management 
No Yes (via extra 
training and 
medical 
director 
approval) 
Yes (via extra 
training and 
medical 
director 
approval) 
Yes 
Trauma and wound care 
and diagnostics 
    
Blood draw No No Yes Yes 
Blood Glucose Analysis 
(BGL) 
No Yes (via extra 
training and 
medical 
director 
approval) 
Yes Yes 
Blood Lactate Analysis  No No No Yes 
Burn Care No Yes Yes Yes 
Cervical Spine 
Immobilization 
Yes Yes Yes Yes 
Childbirth No Yes Yes Yes 
Cold Pack  Yes Yes Yes Yes 
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Extrication No Yes Yes Yes 
Eye Irrigation (Morgan 
Lens)  
No Yes Yes Yes 
Hot Pack No Yes Yes Yes 
Pharmacological 
Restraints  
No No No Yes 
Physical Restraints No Yes Yes Yes 
Selective Spinal 
Assessment 
No Yes (via extra 
training and 
medical 
director 
approval) 
Yes (via extra 
training and 
medical 
director 
approval) 
Yes (via extra 
training and 
medical 
director 
approval) 
Spinal Immobilization Yes Yes Yes Yes 
Splinting No Yes Yes Yes 
Would Care- Occlusive 
Dressings  
No Yes Yes Yes 
Pressure bandages/ 
Tourniquet  
Yes Yes Yes Yes 
Wound Packing No Yes Yes Yes 
EMS Provider Scopes of Practice- represents the 4 different classes of EMS 
professionals as well as their ability to perform specific interventions. IFT: Interfacility 
Transfers 
Information gathered from Massachusetts EMS protocols 88  
As can be seen in Table 3, many of the interventions specifically related to the 
recognition and treatment of sepsis in the hospital are related primarily to ALS level 
ambulance service provided by AEMTs and paramedics. This can also be seen in other 
conditions and one study found that differing levels of EMS care are appropriate for 
different injuries and conditions.89 Specifically in sepsis this includes advanced 
hemodynamic monitoring, capnography, lactate measurement, and IV fluid and 
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medication administration. For this reason, many of the proposed improvements in sepsis 
are addressed to this level of care.  
Current EMS Sepsis Protocols: 
Due to the regional approach taken to EMS protocols there exists less uniformity than 
hospital-based care in most areas. Some agencies have adopted newer models of EMS 
sepsis care while others have not. Iowa, for example, which has uniform EMS policies 
for the entire state, last updated in March of 2018, does not mention the term “sepsis,” 
and simply has a section that addresses distributive shock.90 Other states such as New 
Hampshire have entire sections dedicated to the diagnosis and treatment of both pediatric 
and adult sepsis.91  Table 4 represents many of the varying EMS protocols in use 
currently across the country and highlights the differences of current policies in 6 
different state
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Table 4: Analysis of Sepsis protocols in 6 different States 
 
 
Elements of 
Protocol 
State 
New Hampshire: 
Statewide 
Massachusetts: 
Statewide 
California: San 
Francisco County 
Texas: Fort Worth Washington: 
Northwest Regional 
Iowa: Statewide 
 
 
Sepsis ID 
Criteria 
-Suspected Infection-
Yes  
- Evidence of Sepsis 
criteria 2 or more: 
Temperature <96.8 
degrees Fahrenheit or 
> 101 degrees 
Fahrenheit, Heart Rate 
> 90 bpm, Respiratory 
Rate >20 bpm, 
Systolic BP <90 
mmHG or MAP < 65 
mmHg, New onset 
Altered Mental Status 
or increasing mental 
status change, Serum 
Lactate level > 2 
mmol/L,  
ETCO2 <25mmHg 
-Suspected 
Infection-Yes  
- Evidence of 
Sepsis criteria 2 or 
more: Temperature 
<96.8 degrees 
Fahrenheit or > 
100.4 degrees 
Fahrenheit, Heart 
Rate > 90 bpm, 
Respiratory Rate 
>22 bpm, Systolic 
BP <90 mmHG or 
MAP < 65 mmHg, 
New onset Altered 
Mental Status or 
increasing mental 
status change, 
Serum Lactate 
level > 4 mmol/L,  
ETCO2 <25mmHg 
- Do sepsis screen 
if patient has 
abnormal vital 
signs  
- Does patient 
have a suspected 
or documented 
infection?  
- Evidence of 
Sepsis Criteria 2 or 
more:  
- Temperature> 38 
degrees Celsius or 
< 36 degrees 
Celsius 
- Heart Rate > 90 
bpm 
- Respiratory rate> 
20 bpm 
-No Specific Sepsis 
protocol, listed under 
“shock/hypotension” page 
 If Systolic Blood Pressure 
is < or equal to 90 mmHg 
and/or suspected high risk 
for infection with 2 or more 
of the following: RR > 20 
bpm, HR >90, temperature 
>100.4 degrees Fahrenheit 
-No Specific Sepsis 
protocol listed under 
“Non=traumatic 
Shock”  
- Hypotension, Rales 
and Pulmonary 
Edema, Altered 
Mental Status, 
weakness/dizziness, 
weak or rapid pulse, 
pale, cool or clammy 
skin.  
- No specific 
Sepsis diagnostic 
criteria or protocol 
  
EMT- Basic 
Protocol 
-Routine Patient care 
- Oxygen 
administration for goal 
SpO2 of 94-99% 
- No transport delay 
- If positive screen 
notify receiving 
facility via “Sepsis 
Alert” 
-Routine Patient 
care 
-Oxygen 
administration for 
goal SpO2 of 94% 
-If positive screen 
notify receiving 
facility via “Sepsis 
Alert 
- Position of 
comfort  
- NPO  
- Oxygen as 
indicated 
 
 
 
 
 
 
 
 
- Position patient in supine 
position with legs elevated 
as appropriate and tolerated 
(No Trendelenburg) 
- No specific 
Protocols 
- Maintain SpO2 of 
94-99%  
- Place patient in 
Supine Position 
- If Temperature is 
> 102 degrees 
Fahrenheit cool 
patient 
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AEMT Protocol 
- Rapidly administer 
0.9% NaCl to maintain 
systolic BP >90mmHg 
or MAP of > 65mmHg 
in 500mL boluses. 
Total Volume should 
not exceed 4 Liters. 
Patients should be 
reassessed frequently 
with special attention 
given to lung sounds 
to avoid volume 
overload 
-Full ALS 
assessment and 
treatment  
- Large bore IV 
access  
- IV 0.9% NaCl 
enroute: 
administer 500mL 
boluses up to 
30mL/kg while 
assessing frequent 
lung sounds to 
ensure volume 
overload dose not 
occur 
No specific AEMT 
protocol 
-Normal Saline 20 mL/kg 
IV bolus  
-Titrate to improved vital 
signs and SBP, max of 2 
Liters. Contact medical 
Control if not successful 
- Obtain IV/IO access  
- Fluid Bolus of 
Normal Saline or 
Lactated Ringers 
250mL-1000mL, may 
repeat once if no 
signs of Pulmonary 
Edema for a goal 
SBP of > 100mmHg 
-Same as EMT- 
Paramedic 
 
 
 
 
EMT-Paramedic 
Protocol 
-Obtain serum Lactate 
level if available  
-If there is no adequate 
hemodynamic 
response after 
2,000mL IV fluid  
infused consider: 
Norepinephrine or 
Epinephrine infusion 
-May administer 
additional fluid 
boluses and 
vasopressor 
medications 
Norepinephrine, 
Dopamine, or 
Epinephrine after 
medical control is 
contacted if 
needed 
-Establish IV/IO 
with Normal 
Saline TKO. 
Recommend 2 IV 
Lines 
- If Blood Glucose 
is <60mg/dl, 
unmeasurable or 
patient is known 
diabetic 
administer: 
Dextrose 
- For HR > 100 
bpm or BP < 90 
administer Normal 
Saline fluid bolus.  
- If suspected Sepsis criteria 
and ETCO2 of <25 mmHg 
then contact receiving 
facility with “Sepsis alert” 
- Obtain EKG and 
12-Lead EKG  
- Consider 
Norepinephrine, 
Dopamine, or 
Epinephrine infusion 
for SBP of > 100 
mmHg 
- Administer 20 
mL/kg up to 
500mL of Normal 
Saline or Lactated 
ringers, Repeat for 
goal BP of 
90mmHg 
- Consider 
administering 
Dopamine infusion  
- Consider 
administered 
diphenhydramine 
bolus.  
Presence of 
Pediatric 
Protocol 
Full protocol present 
with additional 
diagnostic criteria and 
interventions 
None present  None Present None Present None Present None Present 
Analysis of Sepsis protocols in 6 different States Note that protocols for higher levels of care would include doing all things in 
lower level of care protocols. Example: EMT-P would be responsible for their specific protocol in addition to AEMT and 
EMT-B protocols. All information in chart was obtained through individual state EMS protocols.88,90–94
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As can be seen in the six states in Table 4, protocols vary widely across the country. 
Out of the states shown, Massachusetts and New Hampshire have very developed sepsis 
protocols compared to those of Washington, or Iowa. However, all six states show 
differences in diagnostic criteria even when addressing the same vital sign or 
intervention. Even more concerning is the lack of standard terminology and absence of 
specific, diagnostic criteria in states such as Washington and Iowa. Many states do not 
even have specific areas of their protocol devoted to sepsis rather, they term it “non-
traumatic shock” and “distributive shock” respectively. These inconsistencies make 
standard communication and education techniques difficult for the NREMT to coordinate 
between states. Providers who are certified at the same level may approach treatment, 
identification, and nomenclature of the disease completely differently within different 
regions. Sepsis-3 attempted to address this in the hospital setting as previously covered. 
The findings of that study have only trickled down into some of the states.  
EMS IMPLEMENTATION AND IMPROVEMENT MEASURES: 
Standardization/Integration of EMS and Hospital Care: 
Hospital based programs that focused on standardizing and streamlining sepsis diagnosis 
and treatment criteria through increased education of ER nurses and implementation of 
specific protocols is one of the most effective means of decreasing mortality.53   With 
estimates of between approximately 1/3 and 1/2 of all sepsis patients presenting to the 
hospital through EMS, similar efforts in the EMS space could lead to a further 
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improvement on recognition and treatment times.81,84 A prospective observational study 
in Canada found that with education and protocol implementation paramedic recognition 
of sepsis in the prehospital settings rose to around 27% with 78.2% accuracy. This is 
significant considering the control group was emergency physicians that were given no 
protocol and only identified 11.3% of patients with sepsis.95 This shows that EMS 
providers are capable of improved identification if provided with proper tools and 
training. 
Diagnostic Tools:  
Lactate:  
Serum lactate and lactic acid readings have become commonplace in hospital settings 
when doing a standard sepsis workup. This is for good reason as lactate has been 
identified as one of the most important indicators of mortality in the hospital in cases of 
severe sepsis.56 Lactate has also been officially recognized in most updated sepsis 
protocols including the Sepsis-3 review as a very valuable sign when compared to others 
for consideration when diagnosing and guiding treatment.9,47 As described in the section 
about hospital lactate readings, bedside POC lactate monitoring has become fairly 
commonplace and could be moved to EMS providers with a small investment of 
education and cost. Some states have already begun to implement the practice in the field 
and lactate readings are listed in multiple state protocols for identifying sepsis (see Table 
4). Despite this lactate monitors are not mandated pieces of equipment on ambulances 
even in places with lactate readings in protocols like Massachusetts.87  Initial studies in 
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the utilization of these meters has found data that suggests elevated lactate in prehospital 
readings appears to correlate to higher ICU admission and sepsis diagnosis. However, no 
statistically significant data has been found yet and more study is needed.85,96 Both 
studies cited here are small in sample size utilizing only 112 patients each. Despite this, 
both studies recognize that lactate monitoring, when coupled with increased education 
can help EMS providers identify sepsis early and more often in acute patients. 85,96 
End Tidal CO2:  
Another vital sign outside of current ALS ambulance monitoring in sepsis is EtCO2. As 
described above, numerous studies have shown that decreased levels of EtCO2 are 
significantly associated with morbidity and mortality in sepsis patients and is therefore a 
good indicator of severity.43 Another study found that it is feasible to take readings easily 
in the ED and that it is statistically associated with both SOFA scores as well as lactate 
levels.42 Similar to lactate readings EtCO2 is a promising tool that can be extended into 
EMS because it is already a vital sign that most ALS ambulances are capable of acquiring 
with current equipment. EtCO2 readings are obtained via a nasal cannula, or inline meter 
unit (for intubated, BIPAP, or CPAP patients) that attaches to a standard cardiac monitor 
carried on ALS ambulances. This is typically utilized in patients experiencing respiratory 
distress, intubated patients, or in resuscitation situations but is not currently utilized in all 
patients.97,98 The fact that this reading can be taken in a non-invasive manner makes it 
easy for providers to utilize in the majority of patients. A retrospective cohort study done 
in Florida also found that EMS is capable of taking accurate readings with the current 
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equipment available on ALS ambulances and that independent of sepsis EtCO2 is a very 
consistent predictor of morbidity and mortality. For this reason, the study suggests 
regular use of it as a vital sign to drive assessment and care.99 A separate prospective 
cohort study then looked at utilization of EtCO2 readings specifically for the diagnosing 
of sepsis in the prehospital setting and was able to show that a protocol incorporating 
both ETCO2 and other SIRS criteria was more accurate in predicting sepsis and was 
therefore suggested as a way to decrease time to interventions.100 Of the current EMS 
protocols reviewed in this paper 2 out of the 6 have ETCO2 listed in potential diagnostic 
criteria for sepsis which shows some potential room for improvement. (Table 4)    
ALS Monitoring:  
In addition to EtCO2 and lactate monitoring, EMS personnel can obtain a large number 
of vital signs and diagnostic information through their normal assessment strategies. 
These items include heart rate, blood pressure (including MAP), pulse oximetry, blood 
glucose, cardiac rhythm, 12-Lead EKG, temperature, and respiratory rate. Many of these 
vitals as shown in the Table 4 criteria and have found their way into the protocol for 
sepsis diagnostic criteria. These core vital signs should be obtained by all ALS 
ambulance crews on any patient with significant signs of injury or illness. It has also been 
hypothesized that arming EMS providers with education on SOFA or qSOFA scores 
would be beneficial in identifying patients who may be septic. These scores were 
specifically developed to be a simplified and quick way of assessing patients and most 
vital sign criteria required can be readily obtained via normal EMS monitoring 
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techniques. However, they have not yet been tested in this setting and therefore the 
effectiveness is not yet known.101   
“Sepsis Alerts”:  
Many potential interventions have been suggested in efforts to improve EMS’s 
involvement in the sepsis care pathway. However, there is currently not a large amount of 
supporting data to show that any of these suggestions are truly effective. A systematic 
review of studies done in the field was completed in 2016 and showed that most 
improvements in outcome that result from EMS do so by improving the process of the 
patient being admitted to the hospital. This accelerated the patient’s recognition and 
treatment on arrival.102 A retrospective cohort study from Australia in 2013 showed that 
EMS often transports the most critically ill sepsis patients. Therefore this continuity of 
care is especially important for these patients.103 Another prospective data analysis of 
approximately 1000 severely septic patients in Philadelphia showed that, on average, 
arriving via EMS improved the time interval between hospital arrival and initiation of 
antibiotic and IVF treatments. EMS patients received antibiotics at 116 minutes vs 152 
minutes for non-EMS arrivals.104 This study also attempted to compare mortality which 
showed no statistically significant difference between EMS and non-EMS arrivals 
however the results were not adjusted to account for the fact that the EMS population 
often is sicker than those who self-admit to the ER.103 This acceleration of the sepsis care 
is important as definitive end goal directed therapies and early initiation is a key factor in 
long term outcomes. Many states with further developed prehospital sepsis protocols, 
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represented by Massachusetts and New Hampshire in Table 4, have instituted “Sepsis 
Alerts” which refers to an alert given by radio or phone to the receiving hospital by the 
EMS crew prior to arrival. The concept is that if a patient meets all sepsis criteria in the 
field and is suspected to have sepsis this method can let the hospital know ahead of time 
to have a team ready to perform a quick analysis of the patient upon arrival and 
subsequently initiate therapy. This protocol can drastically decrease the time required for 
the patient to be triaged and fully assessed by hospital staff. Similar methods have been 
utilized effectively in integration of EMS and hospital care with other time sensitive 
conditions such as CVA, or myocardial infarction.7,8 No studies have evaluated the 
effectiveness of these alert protocols specifically in sepsis as of yet. None the less, sepsis 
protocols are beginning to become more common in more progressive EMS systems.   
EMS Treatment Options: 
Intravenous Fluid Administration:  
It has been previously established that rapid initiation of end goal directed therapy in 
patients with sepsis is the most effective way to combat the disease, however in the 
prehospital setting there is very little evidence of the effectiveness of interventions 
outside of rapid assessment, care, and transport to the hospital thusfar.102  Despite this 
many EMS protocols involve some sort of intervention or supportive measures at the 
very least when a patient appears to meet sepsis criteria. (Table 4) One of the staples of 
sepsis management is the administration of IV fluids as previously covered.53 This is 
often done to combat hypotension seen in most septic patients and has been shown to be 
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effective in decreasing mortality when done in the pre-hospital setting. A 2014 
prospective data analysis of sepsis patients transported via EMS in King County, WA 
showed that patients who either just had an IV placed or had an IV placed and received 
IVF via EMS were associated with a reduction in the chance of organ failure once 
hospitalized.105 This study along with a secondary data analysis of a retrospective cohort 
study done by the same research team on patients in a Pennsylvania tertiary care facility 
showed low levels of both IV access as well as IVF fluid administration in septic 
patients.105,106 The Pennsylvania study showed IVF therapy was initiated via EMS in only 
48% of patients who presented with sepsis. When considering those who were also 
hypotensive upon arrival at the ED still only 64% of them received IVF.106 The other 
study, done 4 years later, showed somewhat lower percentages in terms of IVF 
administration and IV placement. It is worth noting that a different study design and 
different EMS system was utilized here. The results showed that 70% of patients with 
Sepsis did not receive IVF or IV placement via EMS and that in the 30% that did have an 
IV placed only 23% received IVF.105 These numbers show that there is significant room 
for improvement when it comes to this particular intervention. All the equipment and 
skills necessary to complete IVF crystalloid fluid administration that is recommended in 
the Sepsis-3 and SSC guidelines is already available in ALS ambulances nationwide and 
is a standard of care in cases of hypotension and shock.9,52 Increasing education and 
awareness for its specific use in sepsis along with earlier initiation is key in improving 
these metrics.  
Antibiotic Administration:  
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Similar to IVF administration, antibiotics as previously discussed are one of the essential 
aspects of EGDT in the treatment of sepsis. As recommended in the SSC sepsis is 
combated by first administering broad spectrum antibiotics and then tapering these down 
to a more focused approach once the infection causing organism is discovered.52 This 
helps to directly attack and eliminate the infection and decreases the odds of adverse 
effects while also decreasing the chance of developing antibiotic resistant 
microorganisms. Literature regarding the importance of antibiotic timing is mixed. A 
prospective clinical trial done in 2009 in Australia for example showed that treatment of 
patients with antibiotics in EMS according to a guided protocol led to a reduction in the 
delay of antimicrobials once in the hospital and also reduced 28-day mortality.107  On the 
other hand, one large prospective study of ED patients at three different tertiary care 
centers in different states showed no “increase in mortality with each hour delay to 
administration of antibiotics after triage”.108  This conflicting evidence reveals the need 
for more research and study in this area. There also has not yet been any studies done to 
assess the validity of doing such treatment in the United States via EMS.  For the time 
being quick administration of broad-spectrum antibiotics will continue to be utilized in 
the hospital setting under the Sepsis-3 and SSC guidelines. If more trials of antibiotics in 
EMS are successful elsewhere in combating sepsis policy makers may revisit it as a topic. 
Until then, it is unlikely that it will be seen in United States EMS.  
Vasopressor Administration:  
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The final piece of EMS sepsis treatment algorithms currently utilized in each state is the 
use of vasopressor medications in situations where IVF administration is either non-
effective in combating hypotension or it is contraindicated due to issues such as 
pulmonary edema. Most EMS protocols (Table 4) advise administration of substantial 
IVF first before vasopressors are considered. Some states such as Massachusetts, require 
consultation with a medical control physician before proceeding with vasopressor therapy 
as it can produce negative side effects in many patients. Multiple studies have shown that 
in most sepsis cases, the preferred vasopressors are norepinephrine first and dopamine 
second.109 In most states ALS EMS crews are already equipped with both of these 
medications and are already trained in their administration. This is a good option to have 
available in case of need for immediate resuscitation of a patient in critical septic shock 
for hemodynamic support. However, there is little to no data on the effect of EMS 
vasopressor therapy on mortality or survivorship of sepsis.  
Other considerations:  
BLS ambulance care:  
As sepsis is a serious illness that can lead to death, the majority of the diagnostic criteria, 
considerations and potential interventions for pre-hospital sepsis management have been 
focused on ALS ambulance service provided by EMT-Paramedics and AEMTs (Table 3). 
It has been established that septic patients would qualify as appropriate for ALS level of 
care as more serious conditions such as this require a higher level of monitoring and 
intervention.89 Despite this, only about half of sepsis patients transported by EMS do so 
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via paramedics with the other half transported via BLS.84 Thus, it could be beneficial for 
EMS systems to implement protocols that address BLS care as well. Numerous protocols 
(Table 4) allow BLS to use the same diagnostic criteria and do supportive therapies as 
they are capable such as oxygen administration. However, much of the EMS related 
sepsis education is aimed only at ALS providers. Improved BLS education could at least 
provide these individuals with the ability to recognize potential signs of sepsis and then 
get the patient to the appropriate level of care more quickly.      
Community Paramedicine:  
Another exciting innovation in the potential future of EMS sepsis prevention, treatment, 
and integration with the hospital is the novel idea of community paramedicine. 
Community paramedicine programs look to train EMT-paramedics and EMT-basics with 
additional skills that allow them to provide many of the services patients normally have 
to travel to the hospital or primary care physician to receive. This can include screenings 
and tests, including those for the early signs of sepsis or other infection, follow up care 
after hospital discharge to prevent readmission, or even drawing blood for lab work, all in 
the patient’s own home.110,111 Healthcare systems are experimenting with these services 
as they have the ability to decrease hospital admissions and readmissions and cut costs on 
top of improving patient outcomes. These interventions can address patient needs before 
they progress to the point of requiring hospitalization. With many programs still in their 
pilot phases, there is little data available thus far on the effectiveness of these programs.  
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CONCLUSION: 
 This thesis has described many of the changes in the ever-evolving field of sepsis 
care and research. The medical community has progressed immensely in the treatment 
and understanding of this serious disease due to increased interest, innovation, and 
forward thinking on the part of scientists and medical professionals alike. When it comes 
to consolidating all of the new information into care suggestions designed for 
improvement of both care and mortality rates the healthcare community has done a fairly 
thorough job in updating definitions and protocols as represented in the Sepsis-3 
consensus and Surviving Sepsis Campaign respectively. These campaigns have come to 
recognize that the key to effective treatment is prompt recognition and initial treatment 
followed by end goal directed therapy. As this is the gold standard, many developments 
have focused on means to improving these metrics. Many healthcare systems have done a 
great job of implementing these types of developments. This includes the use of novel 
vital signs and tests, such as POC lactate monitoring and ETCO2, to increased education 
and awareness, as well as protocol-based treatments for improved efficiency. More 
standardization could still be accomplished in these hospital programs, but substantial 
progress is being made. Despite this, there is still a large opportunity for improvement 
available in terms of interface and integration of care between the hospital and the EMS 
community in sepsis treatment. Many of the changes that have shown positive results in 
the hospital could be explored or utilized in an ambulance. This thesis has covered how 
many of these changes could be implemented. It suggests that moving forward pre-
hospital providers look to standardize protocols under the NREMT to bring more 
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thorough sepsis protocols to states currently lacking them. In addition, they should adjust 
existing criteria to reflect those generally utilized in hospital systems. These protocols 
should offer explicit diagnostic criteria and clear protocols that focus on fast assessment 
and transport to medical care capable of EGDT with measures to expedite the care in the 
hospital such as “sepsis alerts”. Increased education and awareness programs are also 
required to aid providers in the recognition of the signs of sepsis and septic shock with 
many novel tools such as qSOFA scores, a promising step in the right direction. EMS 
providers should be equipped with diagnostic means that are proven and feasible for use 
in the field such as ETCO2 and POC lactate monitoring to improve diagnostic accuracy 
and ability. Finally, providers should initiate supportive therapy such as IVF 
administration or vasopressor infusions in line with hospital protocols in cases where the 
patient is in serious enough condition. These changes are simple to implement as they do 
not require large amounts of additional equipment or burden on ambulance companies 
but do present a potentially huge improvement in current methods. These changes, 
coupled with the promise of future improvements such as the advent of community 
paramedicine, and means of faster recognition and treatment, should be considered as 
they become viable for use. Hopefully this improved integration of EMS and Hospital 
care drives down the currently high mortality rates and incidences of sepsis and aids in 
combating one of the most serious medical conditions our society currently faces.      
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